Evidence map›Paper›PMID 32942738›Full record

ArticleAntioxidants (Basel, Switzerland)2020

Supplementation Effect of a Combination of Olive (

Michel P Hermans, Philippe Lempereur, Jean-Paul Salembier, Nathalie Maes, Adelin Albert, Olivia Jansen, Joël Pincemail

Open access · goldAbstract read
In one paragraph

Article in Antioxidants (Basel, Switzerland), 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed, 1 pooled it
2.0field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 1 synthesis or guideline pooled it, 36 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Article
  4. Article
  5. Synergistic Beneficial Effects of Flaxseed (Food science & nutrition · 2025
    Review
  6. Review
  7. Article
  8. Review
  9. Article
  10. Review
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Michel P HermansService d'Endocrinologie et de Nutrition and Pôle Endocrinologie, Diabète et Nutrition (EDIN), Institut de Recherche expérimentale et clinique, UCLouvain, 1200 Brussels, Belgium.
Philippe LempereurService de Cardiologie, Centre Hospitalier Bois de l'Abbaye, 4100 Seraing, Belgium.
Jean-Paul SalembierService de Cardiologie, CHU UCL Namur - site Sainte-Elisabeth, 5000 Namur, Belgium.
Nathalie MaesBiostatistics and Medico-economic Information Department, University Hospital of Liège, 4000 Liège, Belgium.
Adelin AlbertBiostatistics and Medico-economic Information Department, University Hospital of Liège, 4000 Liège, Belgium.
Olivia JansenLaboratoire de Pharmacognosie, Centre Interdisciplinaire de Recherche sur le Médicament (CIRM), Université de Liège, 4000 Liège, Belgium.
Joël PincemailDepartment of Cardiovascular Surgery, CREDEC and Platform Nutrition Antioxydante et Santé, CHU and University of Liège, Sart Tilman, 4000 Liège, Belgium.
University of Liège · BECHU Dinant Godinne UCL Namur · BE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe role of herbal products in the prevention of cardiovascular disease requires supporting evidence. This open pilot study assessed the effect of 2-month supplementation of a combination of olive leaf and fruit extracts (Tensiofytol

methodsA total of 663 (pre)-hypertensive patients were enrolled by general practitioners and supplemented for two months with Tensiofytol

resultsSignificant reductions (

conclusionsThis real-life, observational, non-controlled, non-randomized pilot study shows that supplementation of a combination of olive leaf and fruit extracts may be used efficiently and safely in reducing hypertension and MetS markers.

Indexed as

hydroxytyrosolhypertensionmetabolic syndromeOlea europea L.oleuropeinolive extracts

Identifiers

PMID32942738
PMCPMC7554871
OpenAlexW3086712964

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.